Substance / Medication

Emetine hydrochloride

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Amebic acute appendicitis: systematic review of 174 cases.
Otan Emrah, Akbulut Sami, Kayaalp Cuneyt · World J Surg · 2013
PMID: 23665815Meta-Analysis
Evaluation of bithionol as a bath treatment for amoebic gill disease caused by Neoparamoeba spp.
Florent Renee L, Becker Joy A, Powell Mark D · Vet Parasitol · 2007
PMID: 17129675RCT
A comparative study of karyotypes and chromosomal location of rDNA genes in important liver flukes Fasciola hepatica and Fascioloides magna (Trematoda: Fasciolidae).
Reblánová Marianna, Spakulová Marta, Orosová Martina et al. · Parasitol Res · 2011
PMID: 21509448Observational
[Effect of intralesional treatment with emetine hydrochloride on Leishmania (Viannia) braziliensis in hamsters].
Cazorla D, Yépez J, Añez N et al. · Invest Clin · 2001
PMID: 11294031Observational
[Fascioliasis case in the patient with hepatitis A].
Kvitashvili M A, Dvali Sh A, Kokaia I Zh · Georgian Med News · 2005
PMID: 15855700Case Report
Natural infection of a horse with Fascioloides magna.
McClanahan S L, Stromberg B E, Hayden D W et al. · J Vet Diagn Invest · 2005
PMID: 16131000Case Report
Multi level ecological fitting: indirect life cycles are not a barrier to host switching and invasion.
Malcicka Miriama, Agosta Salvatore J, Harvey Jeffrey A · Glob Chang Biol · 2015
PMID: 25778909Preclinical
Prognostic significance of microsatellite alterations at 1p36 in cholangiocarcinoma.
Limpaiboon Temduang, Tapdara Sumonta, Jearanaikoon Patcharee et al. · World J Gastroenterol · 2006
PMID: 16865781PreclinicalFull text (PMC)
An experimental study on triclabendazole resistance of Fasciola hepatica in sheep.
Gaasenbeek C P, Moll L, Cornelissen J B et al. · Vet Parasitol · 2001
PMID: 11163696Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Emetine hydrochloride (substance)
SNOMED CT
12290003
UMLS CUI
C0282162

Clinical Data

This intervention maps to 4 entities in the Ltrl knowledge graph.

4
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.